Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn
Research ArticleArticle

Dihydrofolate Reductase from Trypanosoma equiperdum

I. Isolation, Partial Purification, and Properties

JULIAN J. JAFFE and JOHN J. MCCORMACK JR.
Molecular Pharmacology July 1967, 3 (4) 359-369;
JULIAN J. JAFFE
Department of Pharmacology, University of Vermont, College of Medicine, Burlington, Vermont 05401
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
JOHN J. MCCORMACK JR.
Department of Pharmacology, University of Vermont, College of Medicine, Burlington, Vermont 05401
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

Dihydrofolate reductase was isolated from acetone powder extracts of T. equiperdum. Folic acid was not an effective substrate; indeed, it was a weak inhibitor, the concentration required for 50% inhibition being 3 x 10-5 M. NADPH was a much more efficient hydrogen donor than NADH. Michaelis constants of 4.3 x 10-6 M for dihydrofolate and 1.2 x 10-5 M for NADPH were obtained. Trypanosomal dihydrofolate reductase showed a broad peak of maximal activity between pH 6.0 and 7.7, with activity sharply decreasing above and below those values. Activity increased with increasing temperature within the range of 20°-40°, but fell off sharply above 40°. 4-Amino analogs of folic acid are potent inhibitors of trypanosomal dihydrofolate reductase, the concentration for 50% inhibition by methotrexate, for example, being 2 x 10-10 M. The trypanosomal reductase differs from those of mammalian and bacterial origin with respect to susceptibility to inhibition by a number of 2,4-diaminoheterocyclic compounds.

A substance (or substances) was isolated from homogenates of T. equiperdum which possessed spectrophotofluorometric properties closely resembling those of 2-amino-4-hydroxypteridines and which effectively replaced folic acid as a growth-promoting factor for Lactobacillus casei.

ACKNOWLEDGMENTS The authors wish to express their gratitude to Dr. George Hitchings for his encouragement and for providing us with the diaminoheterocyclic compounds we used in these studies. We also wish to thank Dr. James Burchall for assaying our "pteridine fraction" in his L. casei system. This work was supported by Grant No. CA-08114-03 from the National Cancer Institute, United States Public Health Service, Bethesda, Maryland.

  • Copyright ©, 1967, by Academic Press Inc.

MolPharm articles become freely available 12 months after publication, and remain freely available for 5 years. 

Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page. 

 

  • Click here for information on institutional subscriptions.
  • Click here for information on individual ASPET membership.

 

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
PreviousNext
Back to top

In this issue

Molecular Pharmacology
Vol. 3, Issue 4
1 Jul 1967
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Editorial Board (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Molecular Pharmacology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Dihydrofolate Reductase from Trypanosoma equiperdum
(Your Name) has forwarded a page to you from Molecular Pharmacology
(Your Name) thought you would be interested in this article in Molecular Pharmacology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

Dihydrofolate Reductase from Trypanosoma equiperdum

JULIAN J. JAFFE and JOHN J. MCCORMACK
Molecular Pharmacology July 1, 1967, 3 (4) 359-369;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

Dihydrofolate Reductase from Trypanosoma equiperdum

JULIAN J. JAFFE and JOHN J. MCCORMACK
Molecular Pharmacology July 1, 1967, 3 (4) 359-369;
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Cysteine151 in Keap1 Drives CDDO-Me Pharmacodynamic Action
  • Pharmacological Characterization of the Human α6β4 nAChR
  • Allosteric Modulation of Metabotropic Glutamate Receptor 1
Show more Articles

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics